Mindaros, Romeo P.
HRN: 24-38-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/10/2024
01/16/2024
IVT
300mg
Q6
Necrotic 3rd, 4th Digit Right Foot
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft TissueMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes